 Our goal is to change the way people respond to genetic disease susceptibility. We are going to be doing this by taking our informatics technology and making it available to anyone who can run a sequencing system. By letting people run samples themselves with our molecular techniques and then run our informatics in the cloud, we will let people offer all of our genetic tests, the non-invasive prenatal tests, the tests for other challenges that happen during a pregnancy, the IVF related tests, the carrier screening tests. We will let people run all of our tests at their own hospital labs really close to the bedside and then get the report from us when we analyze the data and use our informatics to generate a diagnostic result in the cloud that can then be acted on immediately by the doctor. I got involved in this field because my sister had a kid with Down syndrome. The child died after six days and it was a horrific thing for a family to go through and I couldn't believe that that could happen in this century that we could not know until the child was born. I think if we had known the child's life would have probably been saved actually. We improve people's quality of lives I think at a high level because we give them accurate information which covers many things and then we support them with that information. So for the panorama test as an example, we cover many more things than just Down syndrome and we give people that peace of mind that they've got a really complete test and then for things that would not have been detected by the other tests like triploidy or for example deletion syndromes which we are about to launch so our goal with the panorama non-invasive prenatal test was to offer something that could be used earlier in the pregnancy than anyone else in the world and also to offer better sensitivity and specificity and coverage than anyone else in the world and we've really achieved that goal. We come at this from a very different approach. We have this multiplex PCR assay which lets us look at 20,000 positions on the chromosomes called SNPs or single nucleotide polymorphisms where I might have an A, you might have a C. So these characterize the genetic differences between people and if you look at our clinical trial data, the performance is unbelievable. We are very close to 100% specificity and 100% sensitivity and the reason why we do so well is because we kind of cheat. We don't make calls unless we know the result really reliably if we don't have a reliable result we'll just ask for another blood draw from the patient. All of these are reasons why the doctors have just been so happy using our test. We actually waited to tell anyone about the pregnancy until we got the results of the panorama test. I can't put into words the gratitude that I have for your whole company. You are incredible people and that is an understatement. And my God, does that make a difference to people's lives? I mean that's just such an uplifting thing for us to be able to use what we have at our disposal to help people address these kinds of challenges. It's a really good feeling.